JCI Review Time

JCI's desk decision is slower than Nature or Cell (which desk-reject in 1-2 weeks) because the editors are evaluating two things simultaneously: is the mechanism deep enough, AND is the disease relevance real?

A paper that's mechanistically elegant but has no disease connection gets rejected. A paper with clear clinical importance but thin mechanism gets rejected. The editor needs to be convinced on both before committing reviewer time. That dual assessment takes longer than a single-axis evaluation.

JCI editors are working scientists (unlike the full-time professional editors at Nature or Cell), which also adds a few days to the triage timeline.

JCI reviewers are asked to evaluate:

• Mechanistic depth: Does the paper explain a disease mechanism with real experimental depth?
• Disease model quality: Are the in vivo or clinical models appropriate? Do they recapitulate human disease?
• Human relevance: Is there human data supporting the translational bridge? Patient samples, clinical cohort validation, or at minimum strong evidence of human relevance?
• Completeness: Are there obvious experiments missing that would strengthen the mechanistic or disease argument?

The dual requirement means reviewers sometimes disagree on which axis is weaker. One reviewer may love the mechanism but question the disease model. Another may find the disease data compelling but want deeper mechanistic evidence. The editor has to reconcile these, which is why first decisions can take time.

Desk rejection at 2-3 weeks: The mechanism or disease connection wasn't convincing. The most common outcome. JCI editors sometimes provide brief feedback explaining which axis was the issue.

Slow desk decision (4+ weeks): The editor may be consulting with a board member or seeking a quick opinion on whether the disease model is adequate. This isn't necessarily bad news.

Review taking 8+ weeks: Normal. Reviewer recruitment for JCI is harder than for pure mechanistic or pure clinical journals because the journal needs reviewers comfortable evaluating both.

Major revision requesting human data: Increasingly common. JCI wants translational evidence. If your paper has strong mouse data but no human validation, expect a revision requesting at least correlative human evidence.

Submit if:

• the paper reveals a disease mechanism with real depth (not just correlation)
• the work has both in vivo/clinical disease models AND mechanistic biochemistry or genetics
• human data or clinical samples support the translational relevance
• the disease angle is integral to the study design, not bolted on

Think twice if:

• the mechanism is strong but the disease connection is speculative
• the clinical data is strong but the mechanism is thin (clinical journals are better)
• JCI Insight would serve the paper with its broader clinical scope
• Nature Medicine's translational focus is a better editorial fit

A free manuscript scan can help assess whether the dual mechanism + disease standard is met before you submit.

How long does JCI take to desk-reject?

Typically 2-3 weeks. Slower than Nature/Cell because editors evaluate both mechanism and disease.

How long does JCI peer review take?

4-6 weeks for reviewer reports, 8-12 weeks total to first decision.

Why is JCI slower than Nature at the desk?

JCI editors are working scientists (not full-time professionals) and they evaluate two axes (mechanism + disease) rather than one. Both factors add time.

Does JCI require human data?

Increasingly, yes. Animal models alone are becoming harder to publish without at least correlative human evidence.